RANDOM NEWS FROM ONCOLOGY RELATED LITERATURE

*A JAPANESE GOVERNMENT FUNDED STUDY, proposed 4 new Bio-markers for pancreatic cancer,
1-Xylitol
2-1,5-anhydro-D-glucitol
3- Histidine
4-Inositol
These are Metabolites implicated in the function of the pancreas and excerbated mechanisms during tumorigenesis

CEA and CA19-9 were also mentioned in the report.

*A STUDY WAS STOPPED FOR BAD OUTCOME!
ADDING CETUXIMAB TO UNSELECTED PATIENTS WITH EARLY STAGE ESOPHAGEAL CANCER RECEIVING CONCURRENT CISPLATIN-XELODA AND RADIATION ADDED TOO MUCH SIDE EFFECTS, AND WORSEN SURVIVAL!

*IN GASTRIC CANCER, RESPONSE BY PET HAS PROGNOSIS MEANING!
PATIENTS WHO SHOWED RESPONSE HAD REPORTEDLY 29.7 MONTHS Vs 14.1 MONTHS FOR NON RESPONDERS
QUESTION IS THIS PET TESTING SENSITIVITY BEING PROVEN, OR IS IT TUMOR RESPONSIVENESS BEING TESTED!  THAT IS CHEMOSENSITIVE TUMORS HAVE BETTER PROGNOSIS!  WELL THE REPORTED WOULD RATHER SAY IT THE PET THAT HAS PREDICTIVE VALUE. YOU DECIDE!

*SUPPORTIVE CARE
ESCITALOPRAM, FOR HEAD AND NECK CANCER PATIENT DEPRESSION
AND DULOXETINE, FOR PERIPHERAL NEUROPATHY!

(THANKS TO THE "ONCOLOGY REPORT"! READ IT!)